peji_banner

News

Chii chaunoda kuziva nezve palmitoylethanolamide (PEA)?

Palmitoylethanolamide (PEA) inongoitika fatty acid amide iyo yakakwezva kutarisisa kune yayo inogona hutano mabhenefiti. Mushonga uyu unowanikwa mumatishu akasiyana siyana mumuviri wese, uye tsvakiridzo inoratidza kuti palmitamideethanol (PEA) inogona kuderedza kuzvimba, kuderedza marwadzo, uye inogona kukurudzira hutano hwematumbo uye kunonoka kuchembera. Inogona kunge iine hutano hwakasiyana-siyana. Zvinyorwa zvinotevera zvichaongorora hutano hwakanaka hwepalmitoylethanolamide (PEA), kuti inoshanda sei pamuviri wemunhu, uye mawaniro epamusoro-soro palmitoylethanolamide (PEA).

Chii chinonzi palmitoylethanolamide (PEA)?

Palmitoylethanolamide (PEA) inowanzoitika endocannabinoid-yakafanana nekomboni inozivikanwa neiyo isingaperi analgesic uye anti-kuzvimba zvivakwa. Pamusoro pekugadzirwa nemuviri, PEA inowanikwa mune zvakasiyana siyana zvekudya zvinosanganisira: chizi, mazai yolk, nyama, mukaka, nzungu, soy lecithin.

waiziva here? Kana muviri ukasangana nezvinoshungurudza, sekukuvara kana kuzvimba, mazinga ePEA anogadzirisa kuchengetedza cellular homeostasis.

Palmitoylethanolamide inobata sei muviri wemunhu?

Masayendisiti haasati anyatsonzwisisa nzira yekuita palmitoylethanolamide. Kunyange zvakadaro, takasvika kure, nekuda kwaProfessor Rita Levi-Montalcini, uyo mu1992-1996 akajekesa nzira yakawanda yekuita palmitoylethanolamide. Kubva ipapo, akaenderera mberi nekudzidza mhedzisiro yepalmitoylethanolamide pamarwadzo europathic uye allergies.

Palmitoylethanolamide inogona kuunza mana makuru ehutano mabhenefiti kuvanhu:

● Bvisa kuzvimba.

●Deredzai mast cell activation (allergies).

●Simbisa basa re endogenous hemp system.

● Activate chaiyo receptors mumuviri.

PEA inoshandisa sei anti-kuzvimba uye analgesic mhedzisiro?

Hutano hunobatsira hwePEA hunosanganisira mhedzisiro pamasero ekudzivirira anodzora kuzvimba, kunyanya muuropi. PEA inogona kubatsira kuderedza kugadzirwa kwezvinhu zvinopisa. Nekudaro, PEA inonyanya kuita pama receptors pamasero, ayo anodzora akasiyana siyana ebasa resero. Aya ma receptors anonzi PPARs. PEA uye mamwe makomisheni anobatsira kumisa PPAR anogona kuderedza marwadzo uye anogona zvakare kuwedzera metabolism nekupisa mafuta, yakaderera serum triglycerides, kuwedzera serum HDL cholesterol, kuvandudza kudzora shuga yeropa, uye kubatsira kuonda.

Palmitoylethanolamide Benefits

Nekuda kweiyo analgesic uye inorwisa-kuzvimba mhedzisiro, tsvakiridzo inoratidza kuti PEA inogona kubatsira neakasiyana-siyana ane chekuita nemarwadzo, akadai se fibromyalgia, sciatica, uye osteoarthritis.

1. Bvisa marwadzo uye mhinduro yekuzvimba

Chirwere chisingaperi idambudziko rakakura rinotambudza varwere pasi rose, uye semakore evanhu, dambudziko iri richava rakakura uye rinokosha. Rimwe remabasa epalmitoylethanolamide nderekuti rinogona kubatsira kubvisa marwadzo uye kuzvimba. palmitoylethanolamide inodyidzana neCB1 uye CB2 receptors, izvo zvakakosha zvikamu zveendogenous hemp system. Iyi sisitimu ine basa rekuchengetedza homeostasis kana kuenzanisa mumuviri.

Kana kukuvara kana kuzvimba mhinduro ikaitika, muviri unoburitsa endo native hemp makomisheni kubatsira kudzora maitiro ekudzivirira. palmitoylethanolamide inogona kubatsira kuwedzera endo native hemp mazinga mumuviri, nekudaro kubvisa marwadzo uye kuzvimba.

Pamusoro pezvo, palmitoylethanolamide inogona kudzikisa kuburitswa kwemakemikari anopisa uye kuderedza yakazara neurological kuzvimba mhinduro. Izvi zvinoita kuti palmitoylethanolamide ive chishandiso chinogona kubatsira kudzora marwadzo uye kuzvimba mhinduro. Zvidzidzo zvinoratidza kuti palmitoylethanolamide inogonawo kushanda kune sciatica kurwadziwa uye carpal tunnel syndrome.

2. Fibromyalgia

Tsvakurudzo dzinoverengeka dzinoratidza kuti PEA inogona kubatsira kuderedza zviratidzo zve fibromyalgia, chirwere chisingaperi chetsinga chinokonzera kurwadziwa kwakapararira. Kana ichishandiswa sechinhu chinopindirana nemishonga yechinyakare, kupinza kwePEA kunoderedza kurwadziwa kwakanyanya uye kunovandudza hupenyu hwekufamba kwenguva. Maererano nekumwe kuongorora, kutora PEA kwemwedzi mitatu zvakanyanya kuderedza marwadzo muvanhu vane fibromyalgia.

3. Kurwadza kwemusana

Kutsvaga kwekutanga kunongedza kune inogona kuita yePEA yekurwadziwa kwemusana. Chidzidzo che 2017 chekucherechedza chakaratidza kuti PEA yakawedzera kuderedza marwadzo ekurwadziwa kune varwere vakakundikana kuvhiya chirwere chekudzoka shure.

Vanhu vanotambura ne sciatica, kurwadziwa kunowedzera kubva pasi pasi pasi pasi rimwe kana makumbo ose, vanogonawo kuwana zororo mushure mekutora PEA. A randomized, double-blind, placebo-controlled controlled trial yakadzidza zvinokonzerwa nepamusoro-uye yakaderera-dose PEA maringe ne placebo. Marwadzo akaderedzwa neanopfuura 50% muboka repamusoro-dose. Kunyange zvazvo yakaderera-dose PEA haina kuwana dhigirii imwechete yekuzorodza marwadzo seyepamusoro-dose, madhizi maviri aive akanyanya kushanda kupfuura placebo.

4. Osteoarthritis

PEA inogona kubatsira kune vanhu vane osteoarthritis, chirwere chinoratidzwa nekuderera kwemajoini cartilage uye bone. Vatori vechikamu mune imwe chidzidzo vakagamuchira PEA vakawana kuvandudzwa kwakakosha muWestern Ontario uye McMaster Universities Osteoarthritis Index (WOMAC) zvibodzwa zvichienzaniswa neboka re placebo. IWOMAC ibhuku remibvunzo rakagadzirirwa kuongorora mamiriro uye zviratidzo (semuenzaniso, kurwadziwa, kuoma, kushanda kwemuviri) kune varwere vane mabvi uye hip osteoarthritis.

Imwe ongororo inosanganisira varwere vane temporomandibular arthritic (TMJ) kurwadziwa kwakabatana neosteoarthritis kwakaratidza kuti PEA supplementation yakavandudza zvakanyanya kurwadziwa kwakanyanya mushure memazuva gumi nemana kana ichienzaniswa neibuprofen. Boka rakapiwa PEA kwemazuva gumi nemana rakaratidza kuvandudzika kukuru mukuvhura muromo kwakanyanya (chiyero chekuzorodza marwadzo) kupfuura boka reibuprofen.

5. Neuropathic kurwadziwa

Zvidzidzo zvekutanga uye kuongororwa kwemhuka zvinoratidza kuti PEA inogona kubatsira nekurwadziwa kweuropathic (kunokonzerwa nekukuvadzwa kwetsinga dzinotakura mameseji pakati pehuropi nemuzongoza), kunyanya kune vanhu vane carpal tunnel syndrome, chirwere cheshuga cheuropathy, chemotherapy Vanhu vane peripheral neuropathy, chisingaperi. kurwadziwa kwepelvic, uye kurwadziwa kunobatanidza nesitiroko uye multiple sclerosis. Mimwe miedzo yekiriniki inodiwa kuti uone kushanda kwePEA mukugadzirisa kurwadziwa kweuropathic.

6. Kukwegura Kweutano

Kunonotsa kuchembera ivavariro youkoshi hunoshanda inoteverwa nemasayendisiti akawanda pasi rose. Palmitoylethanolamide inoonekwa seye-anti-kuchembera yekuwedzera iyo inogona kubatsira kudzivirira maseru kubva kune oxidative kukuvara, inova ndiyo inonyanya kukonzera kuchembera.

Kana maseru akafumurwa kune yakawandisa mahara radical chiitiko, oxidative maitiro anogona kuitika, zvichikonzera kufa kwesero nguva isati yakwana. Kudya kwezvokudya zvisina kunaka, kusvuta, uye zvimwe zvinoratidzwa kwezvakatipoteredza zvakadai sekusvibiswa kwemhepo zvinowedzerawo oxidative damage.Palmitoylethanolamide inogona kudzivirira kukanganisa uku nekubvisa mahara radicals uye kuderedza kuvhiringidzika kwese kwemuviri.

Pamusoro pezvo, palmitoylethanolamide ethanol yakaratidzwa kuti inogona kukurudzira kugadzirwa kwe collagen uye mamwe mapuroteni eganda akakosha. Nokudaro, inogona kuderedza kuonekwa kwemakwinya uye mitsetse yakanaka, ichiita semudziviriri kubva mukati memasero.

Suzhou Myland Pharm & Nutrition Inc. ndeye FDA-yakanyoreswa mugadziri inopa yepamusoro-mhando uye yakakwirira-kuchena Palmitoylethanolamide (PEA) upfu.

PaSuzhou Myland Pharm takazvipira kupa zvigadzirwa zvemhando yepamusoro nemitengo yakanakisa. Yedu Palmitoylethanolamide (PEA) poda inoedzwa zvakasimba kuchena uye potency, kuve nechokwadi kuti iwe unowana yemhando yepamusoro yekuwedzera iwe yaunogona kuvimba nayo. Kunyangwe iwe uchida kutsigira hutano hweserura, kuwedzera immune system yako, kana kuwedzera hutano hwese, yedu Palmitoylethanolamide (PEA) poda ndiyo sarudzo yakakwana.

Iine makore makumi matatu echiitiko uye ichisundwa nehunyanzvi hwepamusoro uye akakwenenzverwa zvakanyanya R&D mazano, Suzhou Myland Pharm yakagadzira mhando yezvigadzirwa zvemakwikwi uye ive yekuvandudza hupenyu hwesainzi yekuwedzera, tsika synthesis uye kugadzira masevhisi kambani.

Uye zvakare, Suzhou Myland Pharm zvakare iri FDA-yakanyoreswa mugadziri. Zviwanikwa zvekambani zveR&D, zvivakwa zvekugadzira, uye zviridzwa zvekuongorora ndezvazvino uye zvinoshanda-akawanda, uye zvinogona kugadzira makemikari kubva kumamirigiramu kusvika kumatani muchiyero, uye zvinoenderana neISO 9001 zviyero uye magadzirirwo ekugadzira GMP.

Disclaimer: Ichi chinyorwa ndecheruzivo rwese chete uye hachifanirwe kutorwa sechero zano rekurapa. Imwe yeruzivo rweblog post runobva kuInternet uye haina hunyanzvi. Iyi webhusaiti inongova nebasa rekugadzirisa, kufomatidza uye kugadzirisa zvinyorwa. Chinangwa chekuendesa rumwe ruzivo hachirevi kuti unobvumirana nemaonero ayo kana kusimbisa uchokwadi hwezvirimo. Nguva dzose bvunza nyanzvi yezvehutano usati washandisa chero chekuwedzera kana kuita shanduko kuhutano hwako hwehutano.


Nguva yekutumira: Sep-13-2024